Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Confab Successfully Completes FDA Audit | Contract Pharma

What are you searching for?

Sign in
Breaking News

Confab Successfully Completes FDA Audit

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quebec-based Confab Laboratories has successfully undergone its second FDA audit for the manufacture and supply of pharmaceutical products to the U.S. The audit was a preapproval inspection for three drug products and demonstrated the company’s conformity to cGMP. Confab’s main focus is to provide manufacturing solutions for nonsterile conventional dosage forms with an efficient turnaround.

Confab’s chief executive officer, Guy Lamarre, commented, “The future looked bright, but this will be a key driver in sustaining our company’s growth in the long term.” The company has increased the size of its facility by 20% in 2006 and is planning its next expansion to meet the needs of its clients and the industry. This year Confab has invested $5 million in its facilities.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters